The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. has made a significant disclosure regarding its stake in Mural Oncology plc as per Form 8.3, aligning with the Irish Takeover Panel Act of 1997 and the takeover rules of 2022. The disclosure notes that Vanguard holds interests amounting to 4.47% in Mural Oncology, representing 772,387 ordinary shares valued at $0.01 each.

As of July 30, 2025, no additional parties related to the offeror or offeree are involved. A minimal sale transaction occurred involving 128 shares at a price of $2.32 per share. There are no cash-settled or stock-settled derivative transactions mentioned in the disclosure.

Furthermore, the disclosure confirms no existing indemnity or dealing arrangements that could influence trading activities. No agreements or understandings concern options or derivative-related voting rights.